Telecom Lead Asia: Agilent Technologies’ Electronic Measurement revenues declined 5 percent to $816 million in fourth quarter from $855 million in the same period last year.
Revenues declined across all key markets with the exception of computer and semiconductor markets. Operating margins were 23 percent.
Agilent Technologies’ revenues for Q4 were $1.77 billion, 2 percent above one year ago.
Fourth-quarter net income was $425 million against $289 million in the same quarter one year ago.
For the full fiscal, Agilent’s income increased to $6.85 billion from $6.61 billion, up 4 percent y-o-y.
Net income of Agilent Technologies for the fiscal increased to $1.153 billion from $1.012 billion.
During the fourth quarter, Agilent had intangible amortization of $52 million; acquisition, integration and transformation costs of $40 million; and a donation to the Agilent Technologies Foundation of $10 million.
Agilent CEO Bill Sullivan said, “Agilent’s performance in the fiscal fourth quarter met our revenue guidance and exceeded EPS guidance. Despite a very challenging economic environment, the strength of our operating model was evident, with operating margins for the quarter and the year at an all-time high.”
Chemical Analysis revenues were down 3 percent compared to a year ago. Environmental and chemical markets were down, offset by growth in the food and forensics markets. Operating margins were 25 percent.
Life Sciences revenues were flat with last year. Growth in the pharma and environmental markets was offset by a decline in academia and government markets. Operating margins were 18 percent.
Diagnostics and Genomics, which includes the Dako acquisition, had revenues of $156 million, up 125 percent over last year or 1 percent excluding the effects of the Dako acquisition. Operating margins were 17 percent.
Fiscal first-quarter 2013 revenues are expected to be in the range of $1.68 billion to $1.70 billion.
For the full fiscal year 2013, Agilent expects revenue of $7.0 billion to $7.20 billion.